Special focus on CBRN and HazMat training

DUBLIN, September 22, 2022 /PRNewswire/ — The “CBRN Defense – Global Market Trajectory & Analytics” report has been added to from ResearchAndMarkets.com offer.

With a market size estimated at $20.8 billion by 2026, this is a healthy prospect for the global CBRN defense market

Amid COVID-19 Crisis, Global CBRN Defense Market Estimated at US$16.7 billion in 2022, is expected to reach a revised size of US$20.8 billion by 2026, growing at a CAGR of 5.8% over the analysis period.

Chemicals, one of the segments analyzed in the report, is expected to grow at a CAGR of 6.7%, while growth in the radiology segment is readjusted to a revised CAGR of 6.1%. Biological warfare is real and a baffling threat to the world as various countries, including the United States, Russia and Chinawere seen as working silently on biological weapons and even keeping an inventory.

Depending on the causative pathogen, the route of inoculation, the size and the immune system of the affected person, these microorganisms hold an incubation period of a few days to a few weeks. Biological weapons can lead to catastrophic large-scale epidemics and serious medical complications or deaths.

Biological warfare raises serious concerns because the technology related to the production of these weapons is relatively affordable and easily accessible. Moreover, the microorganisms necessary for the development of the majority of means of biological warfare are readily available.

Acquisition and release of some of the restricted organisms such as Variola major is possible. It is extremely difficult to keep an eye on the development of biological weapons in all countries, because the production units associated with the approach require little space and are difficult to identify.

Biological weapons have attracted various countries, entities, groups and individuals over the past decades. Various countries have reported a number of acts associated with biological terrorism over the past decades, including a sarin nerve gas attack in Japan in 1995 as well as failed attempts to kill thousands of people.

Countries like the United States and Russia should hold frozen stocks of highly contagious biological warfare agents known to cause incurable diseases, such as anthrax. Intentional or accidental access to these biological weapons by terrorists or rogue politicians can have disastrous consequences.

There are serious concerns about specific inventories of traditional biological agents such as Ebola, anthrax and typhus. On the other hand, various countries have devoted research and other resources to the development of genetically modified organisms. While several countries like Iraq are perceived to possess biological weapons, there is a serious threat from terrorist organizations who may misuse these weapons to trigger an epidemic out of control.

Anthrax remains the most popular choice for the majority of programs targeting biological warfare, as the bacterium is capable of generating deadly spores. Inhalation of these spores in specific amounts can lead to a medical condition which is fatal in nature and requires urgent treatment with large doses of a certain penicillin type antibiotic.

While traditional biological agents such as smallpox and anthrax pose serious threats, various countries are looking beyond these options and exploiting dark biology. The concept of dark biology revolves around the development of genetically modified microorganisms that can be used as biological weapons.

The technology focuses on inserting specific genes into DNA for good or evil purposes. The concept has serious implications because the genetic maps of various deadly microorganisms like bacteria and viruses are available in the public domain and can be exploited for the development of biological weapons.

Researchers recently published the entire genetic code linked to the cholera pathogen. Additionally, the research community is striving to map the genomes of a large number of microbes such as bacteria associated with plague, anthrax, and typhoid. The information can be exploited to develop clones of highly virulent species of viruses and bacteria.

Additionally, misguided microbiologists can be exploited by unscrupulous clients to develop incurable design options like penicillin-resistant anthrax and viruses capable of causing infection while remaining silent.

Russia alleged that Ukraine and the United States works with pathogens known to cause serious infections in various laboratories. Ukraine has several public health laboratories engaged in R&D to find solutions to deal with dangerous infections. A number of these laboratories receive financial and other support from the EU and the United States. Russia’s claims are partly based on the Biological Threat Reduction Program established by the United States in the 1990s to mitigate the risk associated with biological weapons left behind in various countries such as Ukraine.

The program provides financial assistance from the United States for equipment and upgrades. In addition, the US Department of Defense is working with Ukraine for the improvement of public health laboratories since 2005. The United States also offers technical assistance Ukraine and other countries to deal with outbreaks of several infectious diseases.

The United States says these efforts are aimed at mitigating the grave threat of biological weapons proliferation, rather than developing such weapons. On the other hand, Russian officials claim that Ukraine attempts to cover up evidence regarding prohibited activities while working to destroy bio-agents in various labs.

Despite questions about the authenticity of these claims, such claims are perplexing and have brought attention back to chemical and biological warfare. The presence of biological weapons could further aggravate the conflict and raise serious concerns about the misuse of these weapons.

The scenario presents lucrative opportunities for the growth of CBRN defense which is defined as defensive equipment and technologies used against chemical weapons or biological pathogens. CBRN surveillance and countermeasures include advancing detection technologies to cover airborne agents and deposited contaminants. CBRN draws its expertise from information and computer systems, engineering, physics and chemistry enabling end-to-end technological advancements.

What’s new for 2022?

  • Global competitiveness and percentage market shares of main competitors
  • Market presence in multiple geographies – Strong/Active/Niche/Trivial
  • Peer-to-peer collaborative online interactive updates
  • Access to digital archives
  • Free updates for one year

Main topics covered:

I. METHODOLOGY

II. ABSTRACT

1. MARKET OVERVIEW

  • As the threat of biological and chemical warfare becomes real, CBRN defense is moving into the spotlight due to increased emphasis on preparedness and response
  • Russian allegations of biological weapons activities in Ukraine Brings this hidden but ever-present threat back into the spotlight
  • Worries over geopolitical strife and runaway inflation outweigh concerns over receding COVID-19 pandemic
  • Competition
  • Competitive Market Presence – Strong/Active/Niche/Trivial for 83 players globally in 2022 (E)
  • What are biological, chemical and radiation weapons? How do we prepare to protect ourselves against them and what is the role of CBRN defence?
  • Pandemic fails to deter global military spending, which hits record high in 2021, signaling good times for CBRN defense
  • Recent market activity
  • News

2. FOCUS ON CERTAIN PLAYERS (Total 83 featured)

  • AirBoss of America Corp.
  • Argon Electronics Ltd.
  • Avon Protection Systems, Inc.
  • Blucher GmbH
  • Bruker Corporation
  • Chemring Group PLC
  • Crystal Spa
  • Environics
  • FLIR Systems, Inc.
  • Karcher Futuretech GmbH
  • MSA Security, Inc.
  • Smiths PLC Group
  • Thales Group

3. MARKET TRENDS AND DRIVERS

  • As the world increases military spending in the wake of the Russian-Ukrainian war, CBRN defense solutions stand to benefit from the unfortunate state of global geopolitical affairs
  • Accusations of alleged use of chemical and biological weapons in the Russian-Ukrainian war put this dirty battle strategy back in the spotlight
  • Rising Conflicts in the South China Sea to Boost Asian Market Growth
  • Increased activity on the nuclear decommissioning front drives the need for radiation protection and emergency response training during the decommissioning of nuclear facilities
  • The limited success of global efforts to curb the proliferation of biological, chemical and radiation weapons makes CBRN defense necessary for preparedness and response
  • A review of the many reasons the Army is stepping up its focus on equipping infantry with CBRN training tools
  • Radiation protection training takes center stage
  • Special focus on CBRN and HazMat training
  • COVID-19 emphasizes the use of simulators for CBRN training
  • Security focus in CBRNE training grows

4. GLOBAL MARKET OUTLOOK

III. REGIONAL MARKET ANALYSIS

IV. COMPETITION

For more information on this report, visit https://www.researchandmarkets.com/r/jv9w4g

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets